前收市價 | 0.2900 |
開市 | 0.8000 |
買盤 | 1.1500 |
賣出價 | 1.4000 |
拍板 | 245.00 |
到期日 | 2024-06-21 |
今日波幅 | 0.8000 - 2.3000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 241 |
BD's (BDX) robust product portfolio raises optimism about the stock.
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.